UY28827A1 - Formas cristalinas de 5.11-dihidro-11-etil-5-metil-8-(2-((1-oxido-4-quinolinil)oxi)etil)-6h-dipirido(3,2-b:2`, 3`-ee) (1,4)diazepin-6-ona - Google Patents

Formas cristalinas de 5.11-dihidro-11-etil-5-metil-8-(2-((1-oxido-4-quinolinil)oxi)etil)-6h-dipirido(3,2-b:2`, 3`-ee) (1,4)diazepin-6-ona

Info

Publication number
UY28827A1
UY28827A1 UY28827A UY28827A UY28827A1 UY 28827 A1 UY28827 A1 UY 28827A1 UY 28827 A UY28827 A UY 28827A UY 28827 A UY28827 A UY 28827A UY 28827 A1 UY28827 A1 UY 28827A1
Authority
UY
Uruguay
Prior art keywords
etil
diazepin
dipirido
quinolinil
dihidro
Prior art date
Application number
UY28827A
Other languages
English (en)
Inventor
Busacca Carl Alan
Cerreta Michael Kenneth
Lorenz Jon Charles
Smoliga John Andrew
Richard J Varsolona
Vitous Jana
Original Assignee
Boehringer Ingelheim Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34963561&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=UY28827(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Boehringer Ingelheim Int filed Critical Boehringer Ingelheim Int
Publication of UY28827A1 publication Critical patent/UY28827A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/14—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Virology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

Formas cristalinas dihidrato y anhidra de 5, 11-dihidro-11-etil-5-metil-8-(2-((1-óxido-4-quinolinil) oxi)etil)-6H- dipirido(3,2-b:2' , 3' -e) (1,4) diazepin-6-ona.
UY28827A 2004-04-02 2005-03-30 Formas cristalinas de 5.11-dihidro-11-etil-5-metil-8-(2-((1-oxido-4-quinolinil)oxi)etil)-6h-dipirido(3,2-b:2`, 3`-ee) (1,4)diazepin-6-ona UY28827A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US55935404P 2004-04-02 2004-04-02

Publications (1)

Publication Number Publication Date
UY28827A1 true UY28827A1 (es) 2005-10-31

Family

ID=34963561

Family Applications (1)

Application Number Title Priority Date Filing Date
UY28827A UY28827A1 (es) 2004-04-02 2005-03-30 Formas cristalinas de 5.11-dihidro-11-etil-5-metil-8-(2-((1-oxido-4-quinolinil)oxi)etil)-6h-dipirido(3,2-b:2`, 3`-ee) (1,4)diazepin-6-ona

Country Status (19)

Country Link
US (1) US7309700B2 (es)
EP (1) EP1740586A2 (es)
JP (1) JP2007530681A (es)
KR (1) KR20070014164A (es)
CN (1) CN1938306A (es)
AR (1) AR048360A1 (es)
AU (1) AU2005230922A1 (es)
BR (1) BRPI0509586A (es)
CA (1) CA2558817A1 (es)
EA (1) EA200601816A1 (es)
EC (1) ECSP066904A (es)
IL (1) IL178352A0 (es)
MX (1) MXPA06011324A (es)
NO (1) NO20064422L (es)
PE (1) PE20060164A1 (es)
TW (1) TW200602340A (es)
UY (1) UY28827A1 (es)
WO (1) WO2005097796A2 (es)
ZA (1) ZA200605930B (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101541327A (zh) * 2006-01-31 2009-09-23 塔利昂制药公司 法呢基二苯并二氮杂酮的晶体形式
ES2773105T3 (es) * 2012-09-26 2020-07-09 Merck Sharp & Dohme Forma cristalina de un inhibidor de transcriptasa inversa

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI270547B (en) 2000-06-16 2007-01-11 Boehringer Ingelheim Ca Ltd Non-nucleoside reverse transcriptase inhibitors
US6759533B2 (en) 2002-06-28 2004-07-06 Boehringer Ingelheim Pharmaceuticals, Inc. Process and intermediates for making non-nucleoside HIV-1 reverse transcriptase inhibitors

Also Published As

Publication number Publication date
BRPI0509586A (pt) 2007-10-09
AU2005230922A1 (en) 2005-10-20
NO20064422L (no) 2006-09-29
ECSP066904A (es) 2006-12-20
EP1740586A2 (en) 2007-01-10
EA200601816A1 (ru) 2007-04-27
KR20070014164A (ko) 2007-01-31
US20050222134A1 (en) 2005-10-06
JP2007530681A (ja) 2007-11-01
CA2558817A1 (en) 2005-10-20
MXPA06011324A (es) 2007-03-21
PE20060164A1 (es) 2006-04-03
IL178352A0 (en) 2007-02-11
WO2005097796A2 (en) 2005-10-20
WO2005097796A3 (en) 2006-01-05
AR048360A1 (es) 2006-04-19
CN1938306A (zh) 2007-03-28
TW200602340A (en) 2006-01-16
US7309700B2 (en) 2007-12-18
ZA200605930B (en) 2007-12-27

Similar Documents

Publication Publication Date Title
DE60312780D1 (de) Wegwerfwindel
CR8744A (es) Compuestos terapeuticos
EA200801663A1 (ru) КРИСТАЛЛИЧЕСКАЯ ФОРМА 1'-(1-МЕТИЛЭТИЛ)-4'-[(2-ФТОР-4-МЕТОКСИФЕНИЛ)МЕТИЛ]-5'-МЕТИЛ-1H-ПИРАЗОЛ-3'-O-β-D-ГЛЮКОПИРАНОЗИДА, СПОСОБ ЕГО ПОЛУЧЕНИЯ И ЕГО ПРИМЕНЕНИЕ ДЛЯ ПРИГОТОВЛЕНИЯ ЛЕКАРСТВЕННЫХ СРЕДСТВ
DK1944322T3 (da) Behandling af TNFalfa-relaterede sygdomme
DK1633726T3 (da) Pyrimidinderivater, der er egnede til behandling af CRTH2-formidlede sygdomme
DE60324099D1 (de) Arzneistoffhaltiger tampon
ATE409447T1 (de) Bequem windel
DK1701941T3 (da) Forbindelser til behandling af sygdomme med celleproliferation
WO2007023110A3 (en) P38 map kinase inhibitors and methods for using the same
EA200802213A1 (ru) Способы лечения заболеваний крови
DE60223697D1 (de) Wegwerfwindel
NO20053041D0 (no) Behandling av diabetes.
DK1575597T3 (da) Anvendelse af rimexolon til behandling af öjentörhed
DK1496912T3 (da) Kombination af brimonidin og timolol til topisk, ophthalmisk anvendelse
DK1537096T3 (da) Derivater af dioxan-2-alkylcarbamater, fremstilling og terapeutisk anvendelse heraf
DK1411926T3 (da) Integrininhibitorer til behandling af öjensygdomme
NO20045554L (no) Fremgangsmate for behandling av diabetes
DK1487828T3 (da) Morpholinyl-urea-derivater til anvendelse til behandling af inflammatoriske sygdomme
AT500499A3 (de) Mittelpunktbestimmung von justiermarken
DK1516596T3 (da) Forbedret system til behandling af stress-urinkontinens
DK2185561T3 (da) Derivater af 1,2,3,4-tetrahydropyrrolo(1,2-a)pyrazin-6-carboxamid og 2,3,4,5-tetrahydroprrolo(1,2-a)-diazepin-7-carboxamid, fremstilling deraf og terapeutisk anvendelse deraf
ATE333457T1 (de) Zyklische gmp-spezifische phosphodiesteraseinhibitoren
MY140538A (en) Substituted n-acyl-2-aminothiazoles
UY28827A1 (es) Formas cristalinas de 5.11-dihidro-11-etil-5-metil-8-(2-((1-oxido-4-quinolinil)oxi)etil)-6h-dipirido(3,2-b:2`, 3`-ee) (1,4)diazepin-6-ona
CY2011018I1 (el) Νεα κρυσταλλικη μορφη toy 8-kyan-1-kykλoπpoπyλ-7-(1s,6s-2,8-διαζαδικυκλο[4.3.0]εννεαν-8-υλ)-6-φθορο-1,4-διυδρο-4-οξο-3-κινολινο-καρβοξυλικου οξεος

Legal Events

Date Code Title Description
109 Application deemed to be withdrawn

Effective date: 20160509